表纸
市场调查报告书

质子治疗的日本市场:各癌症种类的患者数·偿付政策·治疗患者数

Japan Proton Therapy Market, Patients by 10 Cancer Types(CNS, Head and Neck, Lung, GI, HCC, Pancreas, Gynecologic, Prostate, etc.), Reimbursement Policies & Persons Treated at Centers

出版商 Renub Research 商品编码 427205
出版日期 内容资讯 英文 105 Pages
商品交期: 最快1-2个工作天内
价格
Back to Top
质子治疗的日本市场:各癌症种类的患者数·偿付政策·治疗患者数 Japan Proton Therapy Market, Patients by 10 Cancer Types(CNS, Head and Neck, Lung, GI, HCC, Pancreas, Gynecologic, Prostate, etc.), Reimbursement Policies & Persons Treated at Centers
出版日期: 2019年09月01日内容资讯: 英文 105 Pages
简介

本报告提供日本的质子治疗的市场调查,汇整实际的市场与潜在市场规模的变化与预测,实际患者数和潜在患者数的变化与预测,各癌症种类的市场规模·患者数的变化与预测,偿付政策,标准的质子治疗中心的设备,主要企业分析,市场成长的促进因素·课题分析等资料。

第1章 简介

第2章 调查手法

第3章 摘要整理

第4章 市场变化与预测

  • 实际的市场
  • 潜在市场

第5章 患者数的变化与预测

  • 实际的患者数
  • 潜在的患者数

第6章 患者数的变化与预测:各癌症类型

  • 中枢神经系统 (CNS) 肿瘤
  • 头颈椎癌症
  • 肺癌
  • 消化器官 (GI) 癌症
  • 肝细胞 (HCC) 癌症
  • 胰脏癌
  • 妇产科肿瘤
  • 前列腺癌
  • 骨肿瘤·软组织肿瘤
  • 其他

第5章 市场变化与预测:各癌症类型

  • 中枢神经系统 (CNS) 肿瘤
  • 头颈椎癌症
  • 肺癌
  • 消化器官 (GI) 癌症
  • 肝细胞 (HCC) 癌症
  • 胰脏癌
  • 妇产科肿瘤
  • 前列腺癌
  • 骨肿瘤·软组织肿瘤
  • 其他

第6章 质子治疗中心的清单

  • 运作中
  • 建设中

第7章 治疗中的患者数的转变:各中心

  • 国立癌症中心东医院
  • 兵库县立粒子线医疗中心
  • 筑波大学质子线医学利用研究中心
  • 若狭灣能源研究中心
  • 静冈县立癌症中心
  • 南东北癌症质子治疗中心
  • Medipolis国际质子治疗中心
  • 福井县质子线癌症治疗中心
  • 名古屋质子治疗中心
  • 九州国际重粒子线癌症治疗中心
  • 相泽医院质子治疗中心
  • 北海道大学医院质子治疗中心

第8章 偿付政策

第9章 标准的质子治疗中心的设备

  • 质子加速器
    • 同步加速器 (案例:LLUMC at Loma Linda)
    • 回旋加速器 (案例:MGH Boston)
    • 同步回旋加速器 (案例:Orsay·Uppsala)
    • Linac (线型粒子加速设备)
    • H亏损同步加速器
    • 分离扇回旋加速器
    • 超导性回旋加速器
    • 高速旋转回旋加速器
  • 电子束运输系
  • 射束传送系统
    • 被动散射体法
    • 电子束扫描
  • 管嘴
    • 单一散射
    • 多重散射
    • 均匀扫描
    • 笔形扫描
  • 治疗规划系统
  • 影像放映装置
  • 患者定位系统 (PPS)
  • 人力资源

第10章 企业分析

  • IBA Proton Therapy
  • Varian Medical Systems
  • Elekta

第11章 质子治疗:促进要素

  • 技术进步
  • 日本癌症患者的发生率增加

第12章 质子治疗:课题

  • 大规模投资的必要性
  • 营运上的课题

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录

In Japan, the University of Tsukuba started clinical research and development in the year 1983. This was the first university in Japan that facilitates research and development of proton therapy and it created various milestones at various levels like started treatment of multiple cancerous tumors and creating a worldwide standard of proton therapy etc. In Japan, the number of patients eligibility for proton therapy is much higher than the proton therapy center, which treated the patients. According to our research, Japan is the largest proton therapy hub in Asia. The Japan Proton Therapy Market potential is expected to cross US$ 6 Billion by the end of the year 2025.

Rising cancer prevalence, increasing aging population, growing per capita expenditure, increasing number of proton therapy center in Japan will further boost the proton therapy market in the future course of time. In the early time, proton therapy was used to treat specific kind of cancers like prostate, CNS etc. but now proton therapy technology can treat various cancer at every stage of life; from pediatric to adult and old age also.

Patients Insight - Japan Proton Therapy

This report contains full information about patients, who are likely to get treated with proton therapy, the actual number of patients who have received proton therapy treatment. Moreover we have also categorized the patients on the basis of disease or cancer type into 10 parts; Head and Neck Cancer, Central Nervous System (CNS) Tumors, GI (Gastro-Intestinal) Cancer, Hepatocellular Carcinoma (HCC), Pancreas Cancer, Prostate Cancer, Lung Cancer, Gynecologic Cancers, Bone and Soft Tissue Cancer, Others). We have also provided an in-depth analysis of proton therapy center in Japan, providing a treated patient number by each year and by each operational center in Japan.

Market Insight - Japan Proton Therapy

Japan is one of the largest hubs of proton therapy center in the Asian region. The rising technological development and increasing cutting-edge technology in radiotherapy in Japan will further propel the proton therapy market of Japan in the forecast period. Currently, Japan has XXXX operational proton therapy center and XXXX new under-constructional phase proton therapy center project. The rising new under-contraction proton therapy center in Japan due to cancer patient in Japan is increasing at a rapid pace, and it will continue in the future course of time.

Renub Research report “Japan Proton Therapy Market, Patients by 10 Cancer Types (Central Nervous System (CNS), Head and Neck, Lung, GI (Gastro-Intestinal), Hepatocellular Carcinoma (HCC), Pancreas, Gynecologic, Prostate, Bone and Soft Tissue, Others) Reimbursement Policies & Persons Treated at Centers” provides a comprehensive assessment of the fast-evolving, high-growth of Japan Proton Therapy Market.

The report studies the market and patients numbers, of 10 individual cancer types who are treated under proton therapy. The report also talks about the list of all operational and future Proton Therapy centers; Reimbursement Policies. The report also studies the Proton Therapy Revenue of 3 Companies.

Types of Proton Therapy Market (Actual & Untapped)

  • 1. Actual Market is the current market which is already present.
  • 2. Untapped Market is the market which can be achieved, but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year.

Japan Proton Therapy Market has been analyzed from six viewpoints

  • 1. Actual Market
  • 2. Potential Market
  • 3. Treated Patient Numbers
  • 4. Untapped Patient Numbers
  • 5. Cancer Type - Japan Proton Therapy Market
  • 6. Cancer Type - Japan Proton Therapy Number of Patients

10 Types of Cancer Patient Numbers and Market in Japan Proton Therapy

  • 1. Central Nervous System (CNS) Tumors
  • 2. Head and Neck Cancer
  • 3. Prostate Cancer
  • 4. Lung Cancer
  • 5. GI (Gastro-Intestinal) Cancer
  • 6. Hepatocellular Carcinoma (HCC) Cancer
  • 7. Pancreas Cancer
  • 8. Gynecologic Cancers
  • 9. Bone and Soft Tissue Cancer
  • 10. Others Cancer

Key Companies Covered:

  • 1. IBA (Overview, Sales Analysis)
  • 2. Varian Medical Systems (Overview, Sales Analysis)
  • 3. Elekta (Overview, Sales Analysis)

Table of Contents

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market (Actual & Untapped) - Japan Proton Therapy (2009 - 2025)

  • 4.1. Actual Proton Therapy Market
  • 4.2. Untapped Proton Therapy Market

5. Number of Patients - Japan Proton Therapy (2009 - 2025)

  • 5.1. Actual Numbers
  • 5.2. Untapped Numbers

6. Cancer Types - Japan Proton Therapy Number of Patients (2009 - 2025)

  • 6.1. Central Nervous System (CNS) Tumors
  • 6.2. Head and Neck Cancer
  • 6.3. Lung Cancer
  • 6.4. GI (Gastro-Intestinal) Cancer
  • 6.5. Hepatocellular Carcinoma (HCC) Cancer
  • 6.6. Pancreas Cancer
  • 6.7. Gynecologic Cancers
  • 6.8. Prostate Cancer
  • 6.9. Bone and Soft Tissue Cancer
  • 6.10. Others Cancer

7. Cancer Types - Japan Proton Therapy Market (2009 - 2025)

  • 7.1. Central Nervous System (CNS) Tumors
  • 7.2. Head and Neck Cancer
  • 7.3. Lung Cancer
  • 7.4. GI (Gastro-Intestinal) Cancer
  • 7.5. Hepatocellular Carcinoma (HCC) Cancer
  • 7.6. Pancreas Cancer
  • 7.7. Gynecologic Cancers
  • 7.8. Prostate Cancer
  • 7.9. Bone and Soft Tissue Cancer
  • 7.10. Others Cancer

8. Japan - List of Proton Therapy Centers

  • 8.1. Operating Proton Therapy Centers
  • 8.2. Under-Construction Therapy Centers

9. By Centers - Number of Proton Therapy Patients Treated

  • 9.1. Kashiwa (NCC) Proton Therapy Center (2008 - 2016)
  • 9.2. Hyogo (HIBMC) Proton Therapy Center (2008 - 2016)
  • 9.3. Tsukuba (PMRC, 2) Proton Therapy Center (2008 - 2016)
  • 9.4. WERC Proton Therapy Center (2008 - 2009)
  • 9.5. Shizuoka Proton Therapy Center (2008 - 2016)
  • 9.6. Koriyama-City Proton Therapy Center (2008 - 2016)
  • 9.7. Ibusuki (MMRI) Proton Therapy Center (2011 - 2016)
  • 9.8. Fukui City (Prefectural Hospital) Proton Therapy Center (2013 - 2015)
  • 9.9. Nagoya PTC, Nagoya, Aichi Proton Therapy Center (2013 - 2016)
  • 9.10. Tosu (Saga-HIMAT) Proton Therapy Center (2013)
  • 9.11. Nagano Proton Therapy Center (2014 - 2016)
  • 9.12. Hokkaido Proton Therapy Center (2014 - 2016)

10. Reimbursement Policies - Japan Proton Therapy

11. Components of a Standard Proton Therapy Center

  • 11.1. Type of Proton Accelerator
    • 11.1.1. Synchrotrons (example: LLUMC at Loma Linda)
    • 11.1.2. Cyclotrons (example: MGH Boston)
    • 11.1.3. Synchrocyclotrons (examples: Orsay, Uppsala)
    • 11.1.4. Linacs (Rome)
    • 11.1.5. H-minus Synchrotrons
    • 11.1.6. Separated Sector Cyclotrons
    • 11.1.7. Super-conducting Cyclotrons
    • 11.1.8. Fast Cycling Synchrotron
  • 11.2. Beam Transport System
  • 11.3. Beam Delivery System
    • 11.3.1. The Passive Scattering Technique
    • 11.3.2. Beam Scanning
  • 11.4. Type of Nozzle
    • 11.4.1. Single Scattering
    • 11.4.2. Double Scattering
    • 11.4.3. Uniform Scanning Nozzle
    • 11.4.4. Pencil Scanning Nozzle
  • 11.5. Treatment Planning System
  • 11.6. Image Viewers
  • 11.7. Patient Positioning System (PPS)
  • 11.8. Human Resource

12. Company Analysis (2014 - 2025)

  • 12.1. IBA Proton Therapy
    • 12.1.1. Sales Analysis
  • 12.2. Varian Medical Systems
    • 12.2.1. Sales Analysis
  • 12.3. Elekta
    • 12.3.1. Sales Analysis

13. Proton Therapy - Driving Factors

  • 13.1. Technology Advancement
    • 13.1.1. Next-Generation Proton Technique
  • 13.2. Growing Incidence of Cancer Patients in Japan

14. Challenges

  • 14.1. Requires Huge Investment
  • 14.2. Operation Challenges

List of Figures

  • Figure 2-1: Japan - Proton Therapy Market (Million US$), 2009 - 2018
  • Figure 2-2: Japan - Forecast for Proton Therapy Market (Million US$), 2019 - 2025
  • Figure 2-3: Japan - Untapped Proton Therapy Market (Million US$), 2009 - 2018
  • Figure 2-4: Japan - Forecast for Untapped Proton Therapy Market (Million US$), 2019 - 2025
  • Figure 3-1: Japan - Patient Treated with Proton Therapy (Number), 2009 - 2018
  • Figure 3-2: Japan - Forecast for Patient Treated with Proton Therapy (Number), 2019 - 2025
  • Figure 3-3: Japan - Untapped Patients for Proton Therapy (Number), 2009 - 2018
  • Figure 3-4: Japan - Forecast for Untapped Patients for Proton Therapy (Number), 2019 - 2025
  • Figure 4-1: Japan - Proton Therapy Patients by CNS (Number), 2009 - 2018
  • Figure 4-2: Japan - Forecast for Proton Therapy Patients by CNS (Number), 2019 - 2025
  • Figure 4-3: Japan - Proton Therapy Patients by Head and Neck (Number), 2009 - 2018
  • Figure 4-4: Japan - Forecast for Proton Therapy Patients by Head and Neck (Number), 2019 - 2025
  • Figure 4-5: Japan - Proton Therapy Patients by Lung Cancer (Number), 2009 - 2018
  • Figure 4-6: Japan - Forecast for Proton Therapy Patients by Lung Cancer (Number), 2019 - 2025
  • Figure 4-7: Japan - Proton Therapy Patients by GI Cancer (Number), 2009 - 2018
  • Figure 4-8: Japan - Forecast for Proton Therapy Patients by GI Cancer (Number), 2019 - 2025
  • Figure 4-9: Japan - Proton Therapy Patients by HCC (Number), 2009 - 2018
  • Figure 4-10: Japan - Forecast for Proton Therapy Patients by HCC (Number), 2019 - 2025
  • Figure 4-11: Japan - Proton Therapy Patients by Pancreas (Number), 2009 - 2018
  • Figure 4-12: Japan - Forecast for Proton Therapy Patients by Pancreas (Number), 2019 - 2025
  • Figure 4-13: Japan - Proton Therapy Patients by Gynecologic Cancer (Number), 2009 - 2018
  • Figure 4-14: Japan - Forecast for Proton Therapy Patients by Gynecologic Cancer (Number), 2019 - 2025
  • Figure 4-15: Japan - Proton Therapy Patients by Prostate Cancer (Number), 2009 - 2018
  • Figure 4-16: Japan - Forecast for Proton Therapy Patients by Prostate Cancer (Number), 2019 - 2025
  • Figure 4-17: Japan - Proton Therapy Patients by Bone and Soft Tissue (Number), 2009 - 2018
  • Figure 4-18: Japan - Forecast for Proton Therapy Patients by Bone and Soft Tissue (Number), 2019 - 2025
  • Figure 4-19: Japan - Proton Therapy Patients by Others (Number), 2009 - 2018
  • Figure 4-20: Japan - Forecast for Proton Therapy Patients by Others (Number), 2019 - 2025
  • Figure 5-1: Japan - Proton Therapy Market by CNS (Million US$), 2009 - 2018
  • Figure 5-2: Japan - Forecast for Proton Therapy Market by CNS (Million US$), 2015 - 2025
  • Figure 5-3: Japan - Proton Therapy Market by Head and Neck Cancer (Million US$), 2009 - 2018
  • Figure 5-4: Japan - Forecast for Proton Therapy Market by Head and Neck Cancer (Million US$), 2019 - 2025
  • Figure 5-5: Japan - Proton Therapy Market by Lung Cancer (Million US$), 2009 - 2018
  • Figure 5-6: Japan - Forecast for Proton Therapy Market by Lung Cancer (Million US$), 2019 - 2025
  • Figure 5-7: Japan - Proton Therapy Market by GI Cancer (Million US$), 2009 - 2018
  • Figure 5-8: Japan - Forecast for Proton Therapy Market by GI Cancer (Million US$), 2019 - 2025
  • Figure 5-9: Japan - Proton Therapy Market by HCC (Million US$), 2009 - 2018
  • Figure 5-10: Japan - Forecast for Proton Therapy Market by HCC (Million US$), 2019 - 2025
  • Figure 5-11: Japan - Proton Therapy Market by Pancreas (Million US$), 2009 - 2018
  • Figure 5-12: Japan - Forecast for Proton Therapy Market by Pancreas (Million US$), 2019 - 2025
  • Figure 5-13: Japan - Proton Therapy Market by Gynecologic cancers (Million US$), 2009 - 2018
  • Figure 5-14: Japan - Forecast for Proton Therapy Market by Gynecologic cancers (Million US$), 2019 - 2025
  • Figure 5-15: Japan - Proton Therapy Market by Prostate cancers (Million US$), 2009 - 2018
  • Figure 5-16: Japan - Forecast for Proton Therapy Market by Prostate cancers (Million US$), 2019 - 2025
  • Figure 5-17: Japan - Proton Therapy Market by Bone and Soft Tissue (Million US$), 2009 - 2018
  • Figure 5-18: Japan - Forecast for Proton Therapy Market by Bone and Soft Tissue (Million US$), 2019 - 2025
  • Figure 5-19: Japan - Proton Therapy Market by Others (Million US$), 2009 - 2018
  • Figure 5-20: Japan - Forecast for Proton Therapy Market by Others (Million US$), 2019 - 2025
  • Figure 10-1: Global - IBA Proton Therapy Sales (Million USD), 2014 - 2018
  • Figure 10-2: Global - Forecast for IBA Proton Therapy Sales (Million USD), 2019 - 2025
  • Figure 10-3: Global - Varian Medical Systems Oncology Systems Sales (Million USD), 2014 - 2018
  • Figure 10-4: Global - Forecast for Varian Medical Systems Oncology Systems Sales (Million USD), 2019 - 2025
  • Figure 10-5: Global - Elekta Revenue, (Million USD), 2014 - 2018
  • Figure 10-6: Global - Forecast for Elekta Revenue (Million USD), 2019 - 2025
  • Figure 11-1: Japan - Number of Patient Diagnosed With Cancer (Thousand), 2014 - 2018
  • Figure 11-2: Japan - Forecast for Number of Patient Diagnosed With Cancer (Thousand), 2019 - 2025

List of Tables:

  • Table 6-1: Japan - Proton Therapy Centers in Operation
  • Table 6-2: Japan - Proton Therapy Centers in Under-Construction
  • Table 7-1: Japan - Kashiwa (NCC) Proton Therapy Center with Patients Treated (Number), 2008 - 2016
  • Table 7-2: Japan - Hyogo (HIBMC) Proton Therapy Center with Patients Treated (Number), 2008 - 2016
  • Table 7-3: Japan - Tsukuba (PMRC, 2) Proton Therapy Center with Patients Treated (Number), 2008 - 2016
  • Table 7-4: Japan - WERC Proton Therapy Center with Patients Treated (Number), 2008 - 2009
  • Table 7-5: Japan - Shizuoka Proton Therapy Center with Patients Treated (Number), 2008 - 2016
  • Table 7-6: Japan - Koriyama-City Proton Therapy Center with Patients Treated (Number), 2011 - 2016
  • Table 7-7: Japan - Ibusuki (MMRI) Proton Therapy Center with Patients Treated (Number), 2011 - 2016
  • Table 7-8: Japan - Fukui City (Prefectural Hospital) Proton Therapy Center with Patients Treated (Number), 2013 - 2015
  • Table 7-9: Japan - Nagoya PTC, Nagoya, Aichi Proton Therapy Center with Patients Treated (Number), 2013 - 2016
  • Table 7-10: Japan - Tosu (Saga-HIMAT) Proton Therapy Center with Patients Treated (Number), 2013
  • Table 7-11: Japan - Nagano Proton Therapy Center with Patients Treated (Number), 2014 - 2016
Back to Top